Postinfarction left ventricular remodeling: a pathophysiological and therapeutic review

Area of Science:

• Cardiology
• Pathophysiology
• Pharmacology

Background:

• Left ventricular dysfunction significantly impacts heart failure prognosis, with high mortality rates despite extensive research.
• Current therapeutic strategies have limited long-term efficacy for patients with clinical heart failure.

Purpose of the Study:

• To review the pathophysiology of post-infarction left ventricular dysfunction.
• To provide a rationale for current, clinical trial, and pre-clinical drug development.
• To discuss intracellular signaling pathways in ventricular hypertrophy for future treatments.

Main Methods:

• Literature review of studies on left ventricular dysfunction pathogenesis.
• Analysis of current drug usage and clinical trial data.
• Exploration of pre-clinical compounds and intracellular signaling pathways.

Main Results:

• Numerous therapeutic targets and drug classes have been identified over 50 years.
• Despite advances, long-term prognosis for heart failure patients remains poor.
• Intracellular signaling pathways in ventricular hypertrophy present potential future treatment avenues.

Conclusions:

• Understanding the pathophysiology of left ventricular dysfunction is crucial for improving heart failure outcomes.
• A multi-faceted approach combining current therapies, ongoing trials, and novel pre-clinical research is necessary.
• Targeting intracellular signaling pathways offers promising future therapeutic strategies for heart failure.